Io in Humanitas

Aree mediche di interesse:
Chirurgia dell’apparato digerente, chirurgia colo-rettale, chirurgia oncologica, chirurgia laparoscopica.

Esperienze di lavoro

Ultima esperienza lavorativa
Dal 2018 al 2021: Medico specialista in Chirurgia Generale
Ospedale Buccheri la Ferla, Fatebenefratelli
Palermo
Attività di sala operatoria, attività di guardia, attività di reparto ed ambulatorio presso l’U.O.C. di Chirurgia Generale ed Oncologica

Penultima esperienza lavorativa
Dal 2017 al 2018: Medico specialista in Chirurgia Generale
Fondazione Policlinico Universitario “A. Gemelli” IRCCS
Roma
attività di reparto, ambulatorio e sala operatoria presso   l’U.O.C. di Chirurgia Generale, attività di guardia interdivisionale, guardia chirurgica come secondo di equipe, guardia in Pronto Soccorso

Formazione

Laurea
Corso di Laurea : Medicina e Chirurgia
Anno di Laurea: 2010
Università: Università Cattolica del Sacro Cuore
Roma

Specializzazione
Specializzazione: Chirurgia Generale
Anno: 2017
Università: Università Cattolica del Sacro Cuore
Roma

Master
2017-2018: Master di II livello in Spesi in Chirurgia
Università Cattolica del Sacro Cuore
Roma

Attività e pubblicazioni Scientifiche

Pubblicazioni scientifiche:

  • Lirosi MC, Tirelli F, Biondi A, Mele MC, Larotonda C, Lorenzon L, D’Ugo D, Gasbarrini A, Persiani R. Enhanced Recovery Program for Colorectal Surgery: a Focus on Elderly Patients Over 75 Years Old.  J Gastrointest Surg. 2018 Sep 5. doi: 10.1007/s11605-018-3943-2.
  • Persiani R, Biondi A, Santullo F, Pennestrì F, Tirelli F, Sicoli F, Lirosi MC, Fico V, D’Ugo D. Transanal total mesorectal excision (TaTME): Surgical technique description European Journal of Surgical Oncology 44(4):546; doi: 10.1016/j.ejso.2018.01.043
  • Agnes A, Lirosi MC, Panunzi S, Santocchi P, Persiani R, D’Ugo D. The prognostic role of perioperative allogeneic blood transfusions in gastric cancer patients undergoing curative resection: A systematic review and meta-analysis of non-randomized, adjusted studies. Eur J Surg Oncol. 2018 Jan 12. pii: S0748-7983(18)30014-3. doi: 0.1016/j.ejso.2018.01.006.
  • Lirosi MC, Biondi A, Ricci R. Surgical anatomy of gastric lymphatic drainage. Transl Gastroenterol Hepatol. 2017 Mar 1;2:14.
  • Biondi A, Lirosi MC, D’Ugo D, Fico V, Ricci R, Santullo F, Rizzuto A, Cananzi FC, Persiani R. Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives. World J Gastrointest Oncol. 2015 Dec 15;7(12):389-400.
  • Frongillo F, Bianco G, Silvestrini N, Lirosi MC, Sanchez AM, Nure E, Gaspari R, Avolio AW, Sganga G, Agnes S. Acute Liver Failure in an Adult, a Rare Complication of Alagille Syndrome: Case Report and Brief Review.  Transplant Proc. 2015 Sep;47(7):2179-81.
  • Frongillo F, Lirosi MC, Nure E, Inchingolo R, Bianco G, Silvestrini N, Avolio AW, De Gaetano AM, Cina A, Di Stasi C, Sganga G, Agnes S. Diagnosis and Management of Hepatic Artery Complications After Liver Transplantation. Transplant Proc. 2015 Sep;47(7):2150-5.
  • Nure E, Lirosi MC, Frongillo F, Bianco G, Silvestrini N, Fiorillo C, Sganga G, Agnes S. Overextended Criteria Donors: Experience of an Italian Transplantation Center. Transplant Proc. 2015 Sep;47(7):2102-5.
  • Sganga G, Bianco G, Frongillo F, Lirosi MC, Nure E, Agnes S. Fungal infections after liver transplantation: incidence and outcome. Transplant Proc. 2014 Sep;46(7):2314-8.
  • Frongillo F, Lirosi MC, Sganga G, Grossi U, Nure E, Avolio AW, Bianco G, Mariano G, Agnes S.Graft steatosis as a risk factor of ischemic-type biliary lesions in liver transplantation. Transplant Proc. 2014 Sep;46(7):2293-4.
  • Nure E, Frongillo F, Lirosi MC, Grossi U, Sganga G, Avolio AW, Siciliano M, Addolorato G, Mariano G, Agnes S. Incidence of upper aerodigestive tract cancer after liver transplantation for alcoholic cirrhosis: a 10-year experience in an Italian center.  Transplant Proc. 2013 Sep;45(7):2733-5.
  • Frongillo F, Grossi U, Lirosi MC, Nure E, Sganga G, Avolio AW, Inchingolo R, Di Stasi C, Rinaldi P, Agnes S. Incidence, management, and results of hepatic artery stenosis after liver transplantation in the era of donor to recipient match.  Transplant Proc. 2013 Sep;45(7):2722-5.
  • Sganga G, Bianco G, Fiori B, Nure E, Spanu T, Lirosi MC, Frongillo F, Agnes S. Surveillance of bacterial and fungal infections in the postoperative period following liver transplantation: a series from 2005-2011. Transplant Proc. 2013 Sep;45(7):2718-21.
  • De Gaetano AM, Nure E, Grossi U, Frongillo F, Russo R, Vecchio FM, Lirosi MC, Sganga G, Felice C, Bonomo L, Agnes S Fibrolamellar hepatocellular carcinoma with biliary tumor thrombus: an unreported association. Jpn J Radiol. 2013 Oct;31(10):706-12.
  • Avolio AW, Halldorson JB, Lirosi MC, Lupo L, Nicolotti N, Agnes S. D-MELD, a strong and accurate tool to guide donor-2-recipient matching. Ann Transplant. 2013 Apr 8;18:161-2.
  • Frongillo F, Grossi U, Avolio AW, Sganga G, Nure E, Pepe G, Bianco G, Lirosi MC, Agnes S. Factors predicting ischemic-type biliary lesions (ITBLs) after liver transplantation. Transplant Proc. 2012 Sep;44(7):2002-4.
  • Sganga G, Pepe G, Cozza V, Nure E, Lirosi MC, Frongillo F, Grossi U, Bianco G, Agnes S. Anidulafungin–a new therapeutic option for Candida infections in liver transplantation. Transplant Proc. 2012 Sep;44(7):1982-5.
  • Sganga G, Spanu T, Bianco G, Fiori B, Nure E, Pepe G, D’inzeo T, Lirosi MC, Frongillo F, Agnes S. Bacterial bloodstream infections in liver transplantation: etiologic agents and antimicrobial susceptibility profiles. Transplant Proc. 2012 Sep;44(7):1973-6.
  • Avolio AW, Siciliano M, Barone M, Lai Q, Caracciolo GL, Barbarino R, Nicolotti N, Lirosi MC, Gasbarrini A, Agnes S. Model for end-stage liver disease dynamic stratification of survival benefit. Transplant Proc. 2012 Sep;44(7):1851-6.
  • Avolio AW, Agnes S, Cillo U, Lirosi MC, Romagnoli R, Baccarani U, Zamboni F, Nicolini D, Donataccio M, Perrella A, Ettorre GM, Romano M, Morelli N, Vennarecci G, de Waure C, Fagiuoli S, Burra P, Cucchetti A. http://www.D-MELD.com, the Italian survival calculator to optimize donor to recipient matching and to identify the unsustainable matches in liver transplantation.  Transpl Int. 2012 Mar;25(3):294-301.
  • Avolio AW, Cillo U, Salizzoni M, De Carlis L, Colledan M, Gerunda GE, Mazzaferro V, Tisone G, Romagnoli R, Caccamo L, Rossi M, Vitale A, Cucchetti A, Lupo L, Gruttadauria S, Nicolotti N, Burra P, Gasbarrini A, Agnes S; Donor-to-Recipient Italian Liver Transplant (D2R-ILTx) Study Group.  Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. Am J Transplant. 2011 Dec;11(12):2724-36.
  • AW Avolio , S Agnes, MC Lirosi. Optimization of donor-recipient match and identification of the futile match cutoff. A national Italian study on liver transplantation. Journal of Hepatology 2011; 54, S1:S17.
  • Avolio AW, Barbarino R, Panocchia N, Lirosi MC, Vargiu L, Frongillo F, Grieco A, Agnes S. Mycophenolate mofetil and low doses of calcineurin inhibitors in patients with renal dysfunction after liver transplantation. A ten years single center prospective study. Transplant International 2009; 22, S2: 243-243.
  • Avolio AW, Siciliano M, Barone M, Perilli W, Gaspari R, Annicchiarico B, Nicolotti N, Lirosi MC, Agnes S. The predictive power of donor recipient match. A 4-years analysis of the OPTN database. Liver Transplantation 2009; 15: S117-S117.
  • Avolio AW, Barbarino R, Vargiu L, Lirosi MC, Annicchiarico B, Agnes S, Siciliano M, Frongillo F. Ten years results of mycophenolate mofetil (MMT) and low doses of calcineurin inhibitors (LDCI) in patients with renal dysfunction after liver transplantation.  Liver Transplantation 2009; 15: S244-S244

Capitoli di libro

D’Ugo D, Biondi A, Lirosi MC. Minimal access and robotic surgery. Surgical Oncology: Theory and Multidisciplinary Practice, Second Edition. October 3, 2016 by CRC Press.